7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-09-30 2015-06-30 2015-03-31 2014-09-30 2014-06-30 2014-03-31 2013-09-30 2013-06-30 2013-03-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2004-01-31 
      
    		                                                               
      cash flows from operating activities
    		                                                               
      net income
    		13,889,000 23,034,000 -29,737,000 14,225,000 12,256,000 6,945,000 5,410,000 5,996,000 24,066,000 14,558,000 -14,283,000 4,968,000 6,446,000 13,831,000 8,363,000 1,314,000 21,143,000 8,087,000 13,775,000 10,985,000 10,224,000 -8,960,000 -13,998,000 12,680,000 5,092,000 7,590,000 -1,922,000 31,347,000 5,773,000 6,467,000 -5,454,000 -6,537,000 3,849,000 5,623,000 -860,000 4,064,000 1,991,000 3,382,000 -1,433,000 8,291,000 3,563,000 -4,476,000 4,509,000 5,256,000 -12,375,000 -367,000 2,761,000 -1,366,000 4,981,000 2,899,000 -152,000 4,496,000 48,000 3,606,000 -808,000 3,392,000 -253,000 -11,735,000 -4,089,000 660,000 -1,702,000   
      adjustments to reconcile net income to net cash from operating activities:
    		                                                               
      depreciation and amortization
    		39,799,000 35,993,000 35,483,000 36,016,000 34,979,000 34,475,000 32,368,000 32,686,000 32,210,000 32,180,000 31,315,000 30,668,000 29,229,000 28,862,000 27,118,000 25,422,000 24,605,000 24,011,000 22,656,000 22,259,000 21,247,000 21,355,000 21,934,000 20,414,000 20,490,000 20,083,000 19,620,000 19,477,000 17,480,000 18,086,000 17,856,000 16,477,000 17,053,000 16,612,000 16,654,000 17,069,000 17,318,000 15,811,000 16,412,000 14,601,000 14,941,000 14,294,000 14,423,000 15,199,000 15,571,000 14,762,000 14,528,000 14,760,000 13,369,000 14,893,000 14,892,000 14,955,000 14,309,000 14,296,000 13,921,000 13,844,000 13,002,000 13,876,000 13,275,000 13,821,000 13,593,000   
      noncash operating lease expense
    		15,249,000 14,925,000 14,431,000  15,510,000                                                           
      equity in earnings of joint ventures, net of dividends
    		-3,323,000 1,332,000 -2,599,000  -3,595,000 -2,389,000 -4,324,000 4,164,000 -1,084,000 7,931,000 -1,835,000 2,398,000 -3,084,000 -2,749,000 -2,517,000 1,999,000 -2,853,000 -3,121,000 -2,285,000 1,047,000                                            
      amortization of deferred financing costs and loan discount
    		771,000 743,000 728,000 757,000 795,000 793,000 748,000  746,000 748,000 746,000  648,000 647,000 648,000  649,000 812,000 1,147,000  1,103,000 1,082,000 1,081,000        974,000    814,000    1,368,000                         
      loss on sale and disposal of equipment
    		1,042,000 1,724,000 402,000 1,541,000 148,000                           314,000 420,000   392,000 -66,000   738,000   1,289,000 46,000 246,000 -5,000 192,000 170,000   24,000             
      loss on extinguishment of debt
    		   1,823,000 0            0                                       0 0       
      lease abandonment charges
    		2,819,000 123,000 5,388,000                                                             
      amortization of cash flow hedge
    		-439,000                  925,000 1,244,000 1,312,000                            276,000 275,000 276,000 307,000 306,000 306,000 306,000     1,224,000    
      non-cash change in fair value of interest rate swap
    		2,371,000 1,956,000 2,106,000                                                             
      stock-based compensation
    		9,041,000 8,741,000 28,494,000 8,465,000 4,723,000 4,748,000 11,897,000 5,405,000 4,325,000 4,870,000 12,185,000 4,658,000 3,317,000 4,693,000 11,102,000 3,637,000 4,421,000 8,897,000 8,248,000 2,261,000 2,066,000 1,456,000 6,622,000 1,767,000 1,381,000 1,044,000 4,538,000 1,105,000 1,667,000 1,145,000 3,745,000 945,000 1,528,000 1,038,000 3,276,000 908,000 1,157,000 1,028,000 2,733,000 906,000 2,017,000 3,554,000 433,000 611,000 1,025,000 463,000 630,000 952,000 433,000 531,000 1,175,000 611,000 709,000 742,000 1,048,000 898,000 793,000 1,208,000 819,000     
      loss on impairment
    		   75,000    0                                                        
      change in fair value of contingent consideration
    		   21,000 0 0 1,974,000  -7,210,000 763,000 2,335,000  958,000 -786,000 -501,000  -401,000 1,092,000 200,000  -48,000    204,000 -1,313,000 -640,000                                     
      changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:
    		                                                               
      accounts receivable
    		-6,317,000 147,000 -14,306,000 13,602,000 -3,788,000 -5,716,000 -25,865,000 4,029,000 6,745,000 1,873,000 -9,997,000 6,608,000 -6,120,000 -6,662,000 -23,904,000 17,347,000 4,919,000 -10,663,000 -17,493,000 7,826,000 -11,638,000 18,514,000 10,504,000 -14,015,000 8,575,000 -2,556,000 -9,486,000 11,786,000 -2,528,000 -981,000 -6,132,000 1,606,000 -9,325,000 -12,471,000 -16,974,000 6,222,000 -28,404,000 418,000 -25,291,000 -13,117,000 -6,870,000 -12,498,000 -15,526,000 -13,438,000 -13,923,000 -1,925,000 -11,389,000 -11,782,000 -4,265,000 -2,074,000 -12,023,000 -7,489,000 -13,400,000 -20,984,000 -15,481,000 -8,307,000 -8,711,000 -10,896,000 -8,071,000 -3,536,000 -7,033,000   
      other current assets
    		-20,288,000 29,587,000 -7,206,000 -37,528,000 -504,000 11,519,000 -6,277,000 -14,195,000 1,051,000 6,394,000 -1,691,000 1,607,000 -4,225,000 3,356,000 -4,065,000 -19,135,000 395,000 7,271,000 -4,308,000 -6,934,000 3,638,000 4,720,000 5,164,000 -1,988,000 -5,900,000 5,515,000 -1,184,000 -3,568,000 -5,112,000 -1,571,000 1,003,000 -1,520,000 -1,572,000 510,000 4,043,000 618,000 1,966,000 3,166,000 5,288,000 -12,570,000 -5,845,000 2,787,000 -1,877,000 1,626,000 -4,503,000 -1,081,000 4,676,000 -5,099,000 1,454,000 -1,204,000 -683,000 -1,623,000 -949,000 982,000 -2,345,000 2,449,000 -2,685,000 -1,564,000 -1,426,000 993,000 1,002,000   
      other assets
    		-220,000 -853,000 -1,691,000 18,111,000 -1,835,000 339,000 -5,892,000 15,157,000 -10,051,000 -3,864,000 -2,726,000 -15,904,000 2,456,000 2,699,000 -1,417,000 5,660,000 -1,000 -1,490,000 -3,507,000 -4,725,000 3,557,000 -4,934,000 677,000 3,444,000 -7,839,000 815,000 1,254,000 -478,000 -309,000 1,815,000 -2,715,000 -1,110,000 1,144,000 -843,000 8,000 516,000 531,000 -636,000 856,000 2,433,000 -3,398,000 -289,000 -127,000 630,000 -575,000 -18,000 295,000 -105,000 -22,000 35,000 -64,000 507,000 -237,000 -278,000 51,000 72,000 338,000 901,000 -1,287,000 -541,000 264,000   
      deferred taxes
    		3,513,000 -8,648,000 5,137,000 1,620,000 3,043,000 2,949,000 -1,158,000 -1,333,000 9,638,000 -3,191,000 942,000 4,401,000 4,223,000 3,345,000 1,387,000 9,710,000 4,827,000 2,164,000 3,133,000 7,029,000 4,038,000 -265,000 -11,413,000 342,000 -688,000 -2,061,000 -1,481,000 -8,466,000 1,609,000 2,681,000 -2,759,000 17,473,000 91,000 3,030,000 -1,090,000 1,700,000 1,413,000 1,619,000 -1,286,000 4,604,000 1,724,000 -3,578,000 1,656,000 419,000 -4,536,000 -117,000                  
      operating leases
    		-14,034,000 -12,758,000 -21,968,000  -12,790,000                                                           
      deferred revenue
    		3,789,000 17,000 128,000 -1,104,000 -70,000 -13,000 -172,000 -529,000 122,000 698,000 335,000 493,000 -244,000 -3,046,000 -4,519,000 -8,881,000 -12,291,000 -8,563,000 1,416,000 -6,589,000 146,000 44,356,000 28,000 -592,000 176,000 -226,000 -440,000 -561,000 200,000 48,000 105,000 606,000 -17,000 387,000 58,000 -142,000   -70,000 -77,000 -362,000 -202,000 472,000 171,000 -39,000 100,000 72,000 3,000 140,000 -154,000 86,000 -115,000 -147,000 -44,000 -186,000         
      accounts payable, accrued expenses and other
    		5,165,000 22,606,000 25,658,000 -20,309,000 -409,000 50,996,000 6,839,000  -20,043,000 5,875,000 9,077,000  5,056,000 25,061,000 7,031,000  -5,040,000 608,000 17,157,000  -4,724,000 6,106,000 21,584,000 -2,033,000 16,489,000 -14,129,000 16,989,000 7,584,000 9,041,000 -7,135,000 18,480,000 29,324,000 -157,000 -3,981,000 10,995,000 -4,110,000 -1,944,000 -897,000 11,880,000   6,288,000    -7,433,000 -6,785,000 8,861,000 -7,802,000 568,000 3,979,000             
      net cash from operating activities
    		52,827,000 120,348,000 41,481,000 42,529,000 57,404,000 116,005,000 17,085,000 88,920,000 31,252,000 68,075,000 32,616,000 53,647,000 27,026,000 64,843,000 901,000 49,196,000 41,594,000 30,617,000 28,084,000 63,416,000 38,878,000 90,552,000 40,913,000 21,719,000 38,068,000 17,635,000 26,900,000 28,896,000 40,910,000 22,635,000 24,313,000 66,641,000 25,425,000 19,263,000 30,896,000 36,911,000 3,306,000 30,461,000 20,963,000 12,109,000 10,487,000 17,469,000 14,365,000 24,538,000 -4,860,000 13,733,000 13,556,000 15,221,000 14,801,000 25,386,000 15,431,000 23,584,000 11,185,000 7,671,000 15,196,000 16,730,000 27,658,000 5,894,000 16,602,000 26,368,000 17,430,000 30,395,000 2,425,000 
      capex
    		-60,445,000 -52,943,000 -48,833,000 0 -41,069,000 0 -57,409,000 -40,063,000 -41,157,000 -39,465,000 -55,915,000 -20,845,000 -25,947,000 -36,101,000 -36,558,000 -49,396,000 -34,679,000 -23,375,000 -30,424,000 -16,869,000 -13,110,000 -12,655,000 -51,538,000 -5,884,000 -17,927,000 -17,402,000 -32,940,000 -9,585,000 -17,462,000 -21,187,000 -23,946,000 -8,529,000 -10,160,000 -12,276,000 -30,371,000 -7,141,000 -11,843,000 -17,767,000 -22,500,000 -7,087,000 -11,823,000 -19,826,000 -7,097,000 -9,751,000 -17,047,000 -11,572,000 -15,423,000 -12,926,000 -9,932,000 -11,385,000 -13,962,000 -8,437,000 -9,368,000 -9,299,000 -15,616,000 -7,158,000 -12,317,000 -7,918,000 -12,900,000 -7,947,000 -7,211,000 -14,884,000 -710,000 
      free cash flows
    		-7,618,000 67,405,000 -7,352,000 42,529,000 16,335,000 116,005,000 -40,324,000 48,857,000 -9,905,000 28,610,000 -23,299,000 32,802,000 1,079,000 28,742,000 -35,657,000 -200,000 6,915,000 7,242,000 -2,340,000 46,547,000 25,768,000 77,897,000 -10,625,000 15,835,000 20,141,000 233,000 -6,040,000 19,311,000 23,448,000 1,448,000 367,000 58,112,000 15,265,000 6,987,000 525,000 29,770,000 -8,537,000 12,694,000 -1,537,000 5,022,000 -1,336,000 -2,357,000 7,268,000 14,787,000 -21,907,000 2,161,000 -1,867,000 2,295,000 4,869,000 14,001,000 1,469,000 15,147,000 1,817,000 -1,628,000 -420,000 9,572,000 15,341,000 -2,024,000 3,702,000 18,421,000 10,219,000 15,511,000 1,715,000 
      cash flows from investing activities
    		                                                               
      purchase of imaging facilities and other acquisitions, net of cash acquired
    		-34,479,000                                                               
      purchase of property and equipment and other
    		-60,445,000 -52,943,000 -48,833,000  -41,069,000                                                           
      proceeds from sale of equipment
    		35,000 17,000 23,000 6,000 142,000 7,000 2,000 1,000 9,000 70,000 3,000 896,000 -1,113,000 4,004,000 117,000 104,000 21,000 349,000 151,000 49,000 0 0 779,000 400,000 0 4,000 756,000 -12,000 263,000 208,000 2,116,000   4,000 59,000 418,000 0   443,000 0 205,000 762,000 0 4,000 5,000 235,000 270,000 395,000 36,000 410,000 15,000 19,000 56,000 235,000         
      equity contributions in existing and purchase of interest in joint ventures
    		16,333,000   0 -75,000   -8,582,000 -5,165,000   0 0   0 0   -4,000    0 0   0 0   -1,038,000 0   0 -640,000   0                        
      collection of notes receivable
    		                                                               
      net cash from investing activities
    		-75,724,000 -97,450,000 -56,751,000 -48,813,000 -45,979,000 -77,341,000 -60,937,000 -48,647,000 -46,913,000 -40,354,000 -65,556,000 -123,901,000 -27,060,000 -34,424,000 -61,564,000 -62,005,000 -39,848,000 -32,310,000 -87,348,000 -37,964,000 -20,678,000 -12,543,000 -55,059,000 -5,484,000 -17,136,000 -41,650,000 -35,195,000 -65,148,000 -20,498,000 -31,254,000 -29,849,000 -13,502,000 -19,850,000 -12,002,000 -33,966,000 -6,460,000 -12,483,000 -18,746,000 -27,801,000 22,469,000 -46,495,000 -19,621,000 -14,409,000 -11,313,000 -18,192,000 -13,860,000 -12,347,000 -14,365,000 -10,273,000 -20,686,000 -12,752,000 -41,320,000 -11,235,000 -11,960,000 -23,224,000 -33,761,000 -16,994,000 -31,019,000 -19,608,000 -9,896,000 -7,211,000   
      cash flows from financing activities
    		                                                               
      principal payments on notes and leases payable
    		-1,768,000 -1,743,000 -1,718,000 -1,693,000 -1,672,000      -184,000     0 2,000 -2,477,000 -827,000 -858,000 -890,000 -900,000 -914,000 -1,716,000 -1,458,000 -1,607,000 -1,713,000 -1,698,000 -981,000 -1,657,000 -1,736,000 -1,539,000 -1,528,000 -1,611,000 -2,158,000 -2,661,000 -2,909,000 -3,144,000 -3,166,000 -2,676,000 -1,939,000 -2,030,000 -7,365,000 -7,439,000 -1,929,000 -2,265,000 -2,514,000 -2,697,000 -3,164,000 -3,537,000 -4,479,000 -4,359,000 -3,795,000 -4,112,000 -6,490,000 -5,168,000 -4,961,000 -5,796,000 -5,538,000 -5,976,000 -6,018,000 -7,691,000 -3,975,000 
      payments on term loan debt
    		-5,252,000 -5,252,000 -5,000,000 -4,062,000 -5,937,000 -680,563,000 -1,875,000 -30,001,000 -3,686,000 -3,688,000 -3,688,000 -43,812,000 -3,313,000 -3,312,000 -3,313,000 -3,312,000 -2,938,000 -602,455,000 -10,824,000 -10,824,000 -10,824,000 -10,824,000 -10,824,000 -10,824,000 -10,449,000 -10,449,000 -9,020,000  -8,270,000    -176,271,000    -450,665,000                           
      proceeds from issuance of new debt, net of issuing costs
    		0                                                               
      purchase of noncontrolling interests by third party
    		0                                                               
      payments on contingent consideration and holdbacks
    		                                                               
      distributions paid to noncontrolling interests
    		0 -2,400,000 -913,000 -2,099,000 0   -2,449,000 0           -1,384,000    -1,239,000    -514,000 0   -463,000 -410,000       0 -145,000 -468,000               -33,000 -33,000 -18,000     
      proceeds from sale of economic interests in majority owned subsidiary, net of taxes
    		    -72,000                                                           
      proceeds from issuance of common stock
    		   0 0                                                    0 0 49,000     
      proceeds from issuance of common stock upon exercise of options
    		1,704,000 433,000 121,000 300,000 0 359,000 8,000 70,000 21,000 0 51,000     462,000 0       25,000 0 0 50,000 10,000                                    
      net cash from financing activities
    		-5,316,000 92,428,000 -7,510,000 -2,119,000 -4,335,000 176,106,000 228,298,000 -35,466,000 -3,201,000 238,123,000 -3,821,000 103,585,000 -3,313,000 -3,312,000 -3,313,000 -3,805,000 8,666,000 111,463,000 -11,651,000 -13,066,000 -13,056,000 -87,701,000 68,262,000 -13,754,000 -13,725,000 44,088,000 8,342,000 19,418,000 -9,441,000 -10,081,000 -10,765,000 -10,273,000 -9,830,000 -2,868,000 -9,276,000 -10,135,000 9,099,000 -11,672,000 6,798,000 -3,850,000 41,177,000 2,036,000 -494,000 -12,684,000 14,949,000 131,000 -1,331,000 -728,000 -4,408,000 -6,321,000 -3,305,000 19,990,000 110,000 4,186,000 7,647,000 -6,798,000 -6,673,000 45,601,000 -7,088,000 -7,576,000 -9,021,000   
      effect of exchange rate changes on cash
    		-223,000 503,000 83,000 -493,000 147,000 -71,000 -36,000 -121,000 95,000 -37,000 -229,000 -503,000 -817,000 1,350,000 83,000 -33,000 -11,000 -9,000 -12,000 -107,000 12,000 -7,000 1,000 -4,000 -23,000 3,000 -8,000 -4,000 4,000 -91,000 22,000 -12,000 16,000 20,000 2,000 -36,000 3,000 -20,000 4,000 7,000 -4,000 -37,000 -19,000 -1,000 -18,000 13,000 -58,000 -59,000 34,000 21,000 5,000 -53,000 16,000 22,000 13,000 -6,000        
      net increase in cash and cash equivalents
    		-28,436,000 115,829,000 -22,697,000 -8,896,000 7,237,000 214,699,000 184,410,000 4,686,000 -18,767,000   32,828,000 -4,164,000   -16,647,000 10,401,000 109,761,000 -70,927,000  5,156,000 -9,699,000 54,117,000  7,184,000 20,076,000 39,000         20,280,000 -75,000   30,735,000     -8,121,000   69,000    2,201,000 76,000   -23,835,000 3,986,000       
      cash and cash equivalents, beginning of period
    		0 0 740,020,000 0 0 0 342,570,000 0 0 0 127,834,000 0 0 0 134,606,000 0 0 0 102,018,000 0 0 0 40,165,000 0 0 0 10,389,000 0 0 0 51,322,000 0 0 0 20,638,000 0 0 0 446,000 0 0 307,000 0 0 8,412,000 0 0 362,000 0 0 2,455,000 0 0 0 627,000 0 0 0 10,094,000     
      cash and cash equivalents, end of period
    		-28,436,000 115,829,000 717,323,000 -8,896,000 7,237,000 214,699,000 526,980,000 4,686,000 -18,767,000 265,807,000 90,844,000 32,828,000 -4,164,000 28,457,000 70,713,000 -16,647,000 10,401,000 109,761,000 31,091,000 12,279,000 5,156,000 -9,699,000 94,282,000 2,477,000 7,184,000 20,076,000 10,428,000 -16,838,000 10,975,000 -18,791,000 35,043,000 42,854,000 -4,239,000 4,413,000 8,294,000 20,280,000 -75,000 23,000 410,000 30,735,000 5,165,000 154,000 -557,000 540,000 291,000 17,000 -180,000 431,000 154,000 -1,600,000 1,834,000 2,201,000 76,000 -81,000 259,000 -23,835,000 3,986,000   8,896,000    
      supplemental disclosure of cash flow information
    		                                                               
      cash paid during the period for interest
    		18,661,000 17,008,000 18,010,000 33,081,000 17,317,000 15,918,000 18,285,000 5,274,000 20,120,000 17,830,000 21,471,000 8,900,000 10,564,000 12,239,000 7,448,000 7,634,000 7,634,000 5,507,000 8,267,000 8,311,000 8,384,000 12,892,000 9,934,000 10,196,000 12,766,000 12,996,000 10,296,000 9,880,000 9,627,000 8,459,000 9,050,000 5,063,000 10,111,000 7,988,000 11,035,000 10,668,000   9,085,000 8,260,000 9,659,000 8,624,000 8,925,000 8,956,000 14,508,000 4,822,000 16,261,000 5,531,000 7,623,000 17,610,000 6,841,000 16,463,000 7,618,000 16,899,000 6,330,000 16,773,000 6,722,000 7,517,000 9,340,000 8,046,000 10,214,000 19,297,000 2,535,000 
      cash paid during the period for income taxes
    		1,052,000 2,156,000 272,000 1,968,000 1,497,000 704,000 1,000 1,362,000 24,000 161,000 40,000 27,000 434,000 92,000 34,000 37,000                                                
      in thousands
    		                                                               
      commercial insurance
    		8,867,000 16,414,000 262,488,000 762,952,000 -1,142,000 15,889,000 240,628,000 674,393,000 -1,287,000       557,739,000    423,511,000                                            
      medicare
    		6,923,000 8,132,000 108,199,000 307,220,000 1,133,000 8,194,000 93,525,000 271,977,000 2,417,000       207,748,000    155,224,000                                            
      medicaid
    		873,000 907,000 11,690,000 33,842,000 -107,000 114,000 10,887,000 32,433,000 757,000       26,024,000    18,521,000                                            
      workers' compensation/personal injury
    		705,000 183,000 10,459,000 33,434,000 -765,000 -797,000 11,794,000 37,412,000 -2,869,000       32,681,000    26,295,000                                            
      other payors
    		568,000 1,703,000 27,691,000                                                             
      management fee revenue
    		356,000 409,000 6,279,000 18,434,000 136,000 198,000 5,908,000 13,979,000 -41,000       14,375,000    8,578,000                                            
      other revenue
    		5,071,000 966,000 12,543,000                                                             
      revenue under capitation arrangements
    		1,276,000 -1,883,000 32,050,000 103,012,000 -3,406,000 2,451,000 34,518,000 113,392,000 244,000       111,051,000    105,072,000                                            
      total service revenue
    		24,639,000 26,831,000 471,399,000  1,428,000 28,007,000 431,707,000  -1,747,000                                                       
      amortization of cash flow hedge, net of taxes
    		  1,033,000  986,000 6,517,000 739,000  921,000 922,000 922,000  924,000 924,000 923,000  920,000                                               
      purchase of imaging facilities and other acquisitions
    		  -3,794,000 -5,913,000 -4,977,000            -5,190,000 -7,843,000 -57,075,000  -5,937,000                                           
      equity contributions in existing joint ventures
    		  -4,147,000                                    -294,000    -261,000 -111,000 -789,000                   
      contribution from noncontrolling partners
    		    3,400,000                                                           
      non-cash lease expense
    		                                                               
      equity in earnings of joint ventures, net of dividend
    		                                                               
      gain on contribution of imaging centers into joint venture
    		                                                               
      non-cash change in fair value of interest rate swaps
    		            -12,451,000                                                   
      operating lease liability
    		      -12,883,000 -11,373,000 -14,808,000 -13,502,000 -15,080,000 -19,346,000 -17,378,000 -16,360,000 -15,859,000 -17,518,000 -18,471,000 -18,273,000 -18,291,000 -10,555,000 -13,169,000 -12,837,000 -17,345,000 -17,110,000 -17,453,000 -16,405,000 -15,863,000                                     
      purchase of property and equipment
    		      -57,409,000 -40,063,000 -41,157,000 -39,465,000 -55,915,000 -20,845,000 -25,947,000 -36,101,000 -36,558,000 -49,396,000 -34,679,000 -23,375,000 -30,424,000 -16,869,000 -13,110,000 -12,655,000 -51,538,000 -5,884,000 -17,927,000 -17,402,000 -32,940,000 -9,585,000 -17,462,000 -21,187,000 -23,946,000 -8,529,000 -10,160,000 -12,276,000 -30,371,000 -7,141,000 -11,843,000 -17,767,000 -22,500,000 -7,087,000 -11,823,000 -19,826,000 -7,097,000 -9,751,000 -17,047,000 -11,572,000 -15,423,000 -12,926,000 -9,932,000 -11,385,000 -13,962,000 -8,437,000 -9,368,000 -9,299,000 -15,616,000 -7,158,000 -12,317,000 -7,918,000 -12,900,000 -7,947,000 -7,211,000 -14,884,000 -710,000 
      proceeds from issuance of debt, net of issuance costs
    		                                                               
      sale of noncontrolling interests
    		                                                               
      payments of contingent consideration and holdbacks
    		                                                               
      total revenue
    		                                                               
      non-cash change in fair value of interest rate hedge
    		    6,755,000 1,890,000 -1,216,000  1,015,000 -4,159,000 4,093,000    -20,819,000 -7,521,000 -2,869,000 -35,000 -11,245,000 -1,995,000 680,000                                           
      proceeds from debt refinancing, net of issuing costs
    		    -54,000            0                                               
      payments on contingent consideration
    		    0   -2,105,000                                                        
      other patient revenue
    		    -1,825,000 962,000 11,470,000 31,585,000 273,000       14,598,000    16,986,000                                            
      heart and lung
    		    760,000 15,000 3,921,000                                                         
      other
    		    6,105,000 -186,000 4,395,000 13,938,000 958,000       10,210,000    17,428,000                                            
      imaging center segment revenue
    		    889,000 26,840,000 417,046,000 1,205,080,000 -2,256,000                                                       
      digital health segment revenue
    		    539,000 1,167,000 14,661,000                                                         
      amortization of operating lease right-of-use assets
    		      14,711,000 13,560,000 15,941,000 15,902,000 15,699,000 17,274,000 17,518,000 17,253,000 16,802,000 18,087,000 19,046,000 18,971,000 17,863,000 17,146,000 16,675,000 16,835,000 17,259,000 16,894,000 17,011,000 16,937,000 16,000,000                                     
      loss on sale and disposal of equipment and other
    		      186,000   77,000 579,000          341,000 -569,000 771,000                                         
      purchase of imaging centers and other acquisitions
    		      -3,530,000  -600,000 -671,000 -9,644,000  0 -886,000 -25,123,000                                                 
      principal payments on notes payable
    		      -1,102,000  -877,000                                                       
      contributions from noncontrolling interests
    		      4,169,000                                                         
      proceeds from sale of economic interest of majority owned subsidiary
    		      8,713,000                                                         
      proceeds from issuance of common stock, net of issuance costs
    		      218,385,000 1,000 -371,000                                                       
      amortization and write off of deferred financing costs and loan discount
    		                                   801,000 1,506,000   1,369,000 1,343,000 1,288,000                      
      change in value of contingent consideration
    		                                                               
      accounts payable, accrued expenses and other liabilities
    		                                                               
      purchase of imaging centers and other operations
    		                                                               
      purchase of intangible assets
    		                                                               
      principal payments on notes and leases payable other than term loan debt
    		                                                               
      additional deferred finance costs on revolving loan amendment
    		                   0                                            
      proceeds from debt issuance, net of issuance costs
    		                                                               
      proceeds from sale of economic interest in majority owned subsidiary
    		                                                               
      proceeds from revolving credit facility
    		               0 0 41,200,000 87,100,000 0 0 35,000,000 215,900,000 10,000,000 15,000,000 91,300,000 144,900,000 160,300,000 24,200,000   18,800,000 42,600,000                               
      payments on revolving credit facility
    		               0 0 -41,200,000 -87,100,000 0 0 -115,000,000 -135,900,000 -10,000,000 -15,000,000 -132,300,000 -131,900,000 -132,300,000 -24,200,000   -18,800,000 -42,600,000 -34,300,000 -105,100,000                             
      software and teleradiology
    		                                                               
      ai segment revenue
    		       9,582,000 509,000                                                       
      (gain) on contribution of imaging centers into joint venture
    		                                                               
      (gain) loss on sale and disposal of equipment and other
    		                2,595,000 -1,567,000 -1,307,000                                             
      proceeds from sale of economic interest in majority owned subsidiary, net of taxes
    		                                                               
      teleradiology and software revenue
    		        -2,708,000                                                       
      net decrease in cash and cash equivalents
    		          -36,990,000    -63,893,000              10,975,000 -18,791,000 -16,279,000  -4,239,000 4,413,000 -12,344,000    -36,000   -153,000 -557,000   17,000   154,000 -1,600,000 -621,000    -368,000    -10,094,000     
      gain on extinguishment of debt
    		                                                               
      non cash item in other incomes
    		                                                               
      proceeds from paycheck protection program loans
    		                                                               
      gain on sale and disposal of equipment and other
    		            -247,000 81,000 1,128,000         393,000 917,000                                       
      gain on re-measurement of pre-existing interest
    		                                                               
      other non cash item in other incomes
    		                                                               
      purchase of imaging facilities
    		                      -4,300,000 0 -1,000 -24,149,000 -3,000,000 -55,799,000 -3,299,000 -8,275,000 -5,819,000 -4,708,000 -13,000,000 -6,750,000 -3,154,000 -38,000 0 -1,596,000 -5,007,000 -6,830,000   -7,617,000 -1,451,000 -360,000 -2,293,000 0 -3,625,000 -700,000 -9,337,000 -580,000 -29,304,000 -2,157,000 -5,186,000 -6,343,000 -27,194,000 -4,771,000 -23,101,000 -6,708,000 -2,168,000 0   
      equity investments at fair value
    		                        0 0 -143,000                                     
      proceeds from the sale of equity interests in a joint venture
    		                       0 0 0 132,000                                     
      nulogix return of capital
    		                       0                                        
      contributions from noncontrolling partners
    		                               0 0                               
      imaging on call and software
    		                                                               
      service fee revenue
    		               871,336,000    674,992,000                                            
      deferred rent
    		                           3,915,000 609,000 486,000 1,302,000 -2,000 307,000 -146,000 1,976,000 -990,000 -1,730,000   1,432,000                        
      proceeds from sale of internal use software
    		                                                               
      proceeds from sale of noncontrolling interest
    		                       0 0 0 5,275,000                                     
      purchase of noncontrolling interests
    		                                                               
      net increase increase in cash and cash equivalents
    		                                                               
      other non-cash items included in cost of operations
    		                                                               
      proceeds from debt issuance, net of issuing costs
    		                                                               
      proceeds from payment protection program
    		                    0                                           
      contribution from noncontrolling partner
    		                        0 0 750,000                                     
      equity in earnings of joint ventures
    		                     -945,000 -1,955,000  -1,955,000 -2,244,000 -1,873,000 -1,830,000 -2,822,000 -3,748,000 -2,977,000 -5,182,000 -3,450,000 -2,994,000 -1,928,000 -1,638,000 -2,576,000 -3,274,000 -2,279,000 -1,992,000 -3,207,000 -1,102,000 -2,009,000 -1,646,000 -1,067,000 -1,617,000 -1,658,000 -1,206,000 -909,000 -1,986,000 -1,262,000 905,000 -1,822,000 -2,083,000 -2,224,000 -2,116,000 -2,282,000 -1,971,000 -1,861,000 -1,617,000 -1,751,000   
      distributions from joint ventures
    		                        486,000   3,063,000 14,700,000 4,262,000 2,821,000 1,905,000 2,792,000 1,670,000 2,323,000 -3,000 831,000 60,000 2,038,000 60,000 3,154,000 3,041,000 2,317,000 3,175,000 1,866,000 1,653,000 2,050,000 1,921,000 2,151,000 1,800,000 1,575,000 -1,415,000 2,482,000 1,422,000 2,504,000 2,578,000 2,581,000 2,663,000 3,095,000 815,000 2,489,000   
      other noncash items included in cost of operations
    		                        0                                       
      benefit from bad debts
    		                               11,368,000 11,687,000 11,854,000 11,646,000 11,504,000 11,253,000 12,326,000 10,304,000 9,433,000 8,387,000 7,475,000 7,532,000 7,520,000 6,893,000       9,418,000 8,608,000 8,748,000 7,905,000 8,555,000 8,458,000 8,468,000 7,677,000 7,975,000 8,386,000   
      gain on sale of imaging centers
    		                               0 -845,000             0                  
      non cash severance
    		                               0                                
      investment at cost
    		                               0 0 0 -500,000                             
      proceeds from sale of imaging and medical practice assets
    		                               -571,000                                
      cash contribution from partner in jv formation
    		                                                               
      service fee revenue, net of contractual allowances and discounts
    		                                                               
      net service fee revenue
    		                                                               
      total net revenue
    		                                                               
      proceeds from debt issuance
    		                        -2,856,000                                       
      amortization deferred financing costs and loan discount
    		                         1,046,000 975,000  975,000    873,000                               
      deferred financing costs from debt issuance
    		                                                               
      debt discount from debt issuance
    		                                                               
      gain on sale and disposal of equipment
    		                          971,000        -45,000              -45,000   -312,000 -331,000           
      noncash items included in cost of operations
    		                          -559,000                                     
      gain on return from common stock
    		                                                               
      (gain) loss on sale and disposal of equipment
    		                           150,000 -373,000             -38,000                      
      proceeds from borrowings
    		                               0    1,000    0   0 0 210,000,000            0       
      payments on senior notes
    		                                          0 -6,876,000 -204,468,000                   
      payments on deferred financing costs and debt discount
    		                                                               
      proceeds from sale of noncontrolling interest, net of taxes
    		                               -6,000 2,876,000                               
      cash distribution from new jv partner
    		                                0                               
      deferred financing costs and debt discount
    		                                -4,497,000 0 -570,000                             
      purchase of non-controlling interests
    		                                   -803,000                            
      proceeds from sale of imaging facilities
    		                                             0   0 0 2,300,000         0 0   
      gain on sale of equipment
    		                              -1,936,000                                 
      investments at cost
    		                              -2,200,000                                 
      payments on term loan debt/senior notes
    		                              -8,270,000    -6,063,000    -6,178,000 -6,179,000 -6,179,000 -5,190,000                      
      proceeds on revolving credit facility
    		                                  105,100,000                             
      dividends paid to noncontrolling interests
    		                              -759,000    -485,000    -158,000                         
      gain from return of common stock
    		                                    0                           
      gain on return of common stock
    		                                                               
      loss on early extinguishment of senior notes
    		                                          0 471,000 15,456,000                   
      deferred financing costs
    		                                   0    0   0 0 -6,650,000 0      -727,000 0 1,000 -218,000 -206,000 -168,000       
      net (payments) proceeds on revolving credit facility
    		                                                               
      proceeds from the sale of non-controlling interests
    		                                                               
      proceeds from issuance of common stock upon exercise of options/warrants
    		                                   0 0   0 270,000 324,000 760,000 757,000 29,000 0 0 469,000    0 0 143,000 99,000         
      cash distribution from existing jv partner
    		                                                               
      net proceeds (payments) on revolving credit facility
    		                                                               
      distributions paid to non-controlling interests
    		                                                               
      proceeds from sale of non-controlling interests
    		                                                               
      net proceeds (repayments) on revolving credit facility
    		                                                               
      deferred rent amortization
    		                                      443,000   925,000 233,000 77,000 343,000 1,049,000 1,411,000 433,000 408,000 2,294,000 288,000 363,000 609,000 1,205,000 105,000 -27,000 338,000 1,178,000 359,000 480,000 240,000   
      net proceeds on revolving credit facility
    		                                      16,300,000  -24,700,000 9,400,000                      
      accounts payable , accrued expenses and other
    		                                       821,000                        
      amortization of deferred financing costs
    		                                          560,000 596,000 552,000                   
      write off of deferred loan costs due to refinance
    		                                          0 0 665,000                   
      amortization of bond and term loan discounts
    		                                          728,000 727,000 616,000   400,000                
      proceeds from sale of joint venture interests
    		                                             0                  
      distributions to noncontrolling interests
    		                                          -9,000 -6,000 -133,000 -4,000   -3,000 -38,000 -26,000 -43,000 -40,000 -38,000 -33,000     -28,000    
      accounts payable and accrued expenses
    		                                           3,098,000 -11,075,000       2,158,000 220,000 829,000 9,335,000 -7,042,000 14,863,000 -6,902,000 7,337,000 4,607,000 -4,466,000   
      net proceeds (payments) on line of credit
    		                                                               
      proceeds from, net of payments on, line of credit
    		                                            18,100,000   1,500,000 300,000 -1,200,000 2,700,000 26,700,000 5,600,000 9,800,000 15,900,000         
      benefit from bad debt
    		                                             7,033,000 6,955,000 6,822,000 6,574,000 6,395,000 6,484,000             
      amortization of deferred financing cost
    		                                             610,000 609,000 457,000 767,000 771,000 771,000   719,000 748,000     669,000 669,000   
      amortization of bond and term loan discount
    		                                             626,000                  
      gain on de-consolidation of joint venture
    		                                                               
      purchase of equity interest in joint ventures
    		                                             0 -1,079,000 -724,000 -1,836,000 0 -920,000 -3,594,000 0 0 -1,500,000     0 0   
      proceeds from borrowings upon refinancing
    		                                             0                  
      net (payments on) proceeds from line of credit
    		                                             2,400,000                  
      payments to counterparties of interest rate swaps, net of amounts received
    		                                                -1,541,000 -1,546,000 -1,500,000 -1,581,000 -1,655,000 -1,608,000 -1,611,000 -1,599,000        
      proceeds from sale of noncontrolling interests
    		                                               2,640,000                
      amortization of bond discount
    		                                                68,000 67,000 65,000 64,000 61,000 61,000 58,000 57,000 56,000       
      proceeds from insurance claims on damaged equipment
    		                                                   0 271,000           
      gain on bargain purchase
    		                                                           0 0   
      repayment of debt
    		                                                        0       
      loss on sale of equipment
    		                                                      259,000  451,000 51,000 104,000     
      adjustments to reconcile net income
    		                                                               
      to net cash from operating activities:
    		                                                               
      net income on disposal of assets
    		                                                           148,000    
      changes in operating assets and liabilities, net of assets
    		                                                               
      acquired and liabilities assumed in purchase transactions:
    		                                                               
      proceeds from borrowings on notes payable
    		                                                               
      repayment of bebt
    		                                                               
      net payments on line of credit
    		                                                               
      deferred financing cost amortization
    		                                                               
      gain on bargin purchase
    		                                                               
      proceeds from sale of imaging equipment
    		                                                               
      payments on line of credit
    		                                                               
      deferred financing cost interest expense
    		                                                         695,000 670,000     
      payments to counterparties of cash flow hedges
    		                                                               
      distributions to counterparties of cash flow hedges
    		                                                          -1,581,000 -1,588,000 -1,509,000   
      gain from sale of joint venture interests
    		                                                               
      adjustment to purchase of radio logix, net of cash acquired
    		                                                               
      proceeds from the divestiture of imaging centers
    		                                                               
      purchase of covenant not to compete contract
    		                                                               
      payments collected on notes receivable
    		                                                               
      cash and cah equivalents, beginning of period
    		                                                               
      share-based compensation
    		                                                            713,000   
      net (payments) proceeds on line of credit
    		                                                            -1,406,000   
      net increase in cash
    		                                                              -29,000 
      net gain on disposal of assets
    		                                                               
      net decrease in cash
    		                                                               
      the accompanying notes are an integral part of these financial statements
    		                                                               
      net cash used by investing activities
    		                                                              -710,000 
      borrowings on lines of credit
    		                                                              1,231,000 
      proceeds from issuance of convertible subordinated note payable
    		                                                              1,000,000 
      joint venture distributions
    		                                                               
      net cash used by financing activities
    		                                                              -1,744,000 
      cash, beginning of period
    		                                                              30,000 
      cash, end of period
    		                                                              1,000 
      •
    		                                                               
      depreciation and amortization - continuing operations
    		                                                               
      depreciation and amortization - discontinued operations
    		                                                               
      deferred income tax benefit
    		                                                               
      gain on write-downs and settlement of obligations
    		                                                               
      gain on sale of assets and operating sites
    		                                                               
      employee stock compensation
    		                                                               
      imputed interest expense
    		                                                               
      minority interest in earnings of continuing subsidiaries
    		                                                               
      minority interest in earnings of discontinued subsidiaries
    		                                                               
      changes in assets and liabilities:
    		                                                               
      unbilled receivables
    		                                                               
      accounts payable, accrued expenses and disbursements in transit
    		                                                               
      income taxes payable
    		                                                               
      acquisition of imaging centers
    		                                                               
      proceeds from sale of divisions, centers, and equipment
    		                                                               
      proceeds from short and long-term borrowings
    		                                                               
      purchase of subordinated debentures
    		                                                               
      joint venture proceeds
    		                                                               
      cash, beginning of year
    		                                                               
      cash, end of year
    		                                                               
      cash paid during the year for interest
    		                                                               
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.